Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00565995
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IH3 | 2-(2,2-DIPHENYL-ETHYL)-7-METHYL- 1,3-DIOXO-2,3,5,8-TETRAHYDRO-1H- [1,2,4] TRIAZOLO[1,2-A]PYRIDAZINE- 5-CARBOXYLIC ACID [4-(2-AMINO-3H- IMIDAZOL-4-YL)-CYCLOHEXYL]-AMIDE | 2,3 | 1C4Y | 0.7 | |
654 | 4-(2-THIENYL)-1-(4-METHYLBENZYL)- 1H-IMIDAZOLE | A,B | 1I2Z | 0.74 | |
NZO | nocodazole | A,B | 3EE2 | 0.71 | |
REM | Nalpha-[(2S)-2-benzyl-3-(tert-butylsulfonyl)propanoyl]- N-[(1S,2R,3S)-1-(cyclohexylmethyl)- 3-cyclopropyl-2,3-dihydroxypropyl]- L-histidinamide | A,B | 3D91 | 0.72 | |
IZ1 | N-[(1S)-2-{4-[(5S)-1,1-dioxido- 3-oxoisothiazolidin-5-yl]phenyl}- 1-(4-phenyl-1H-imidazol-2-yl)ethyl]- 3-(trifluoromethyl)benzenesulfonamide | A | 2VEU | 0.72 | |
IZ2 | N-[(1S)-1-(4-benzyl-1H-imidazol- 2-yl)-2-{4-[(5S)-1,1-dioxido-3- oxoisothiazolidin-5-yl]phenyl}ethyl]- 3-(trifluoromethyl)benzenesulfonamide | A | 2VEV | 0.71 | |
HA3 | N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2- a]pyrazin-7(8H)-yl)carbonyl]thiophene- 2-carboxamide | A,B | 2VQV | 0.73 | |
HA3 | N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2- a]pyrazin-7(8H)-yl)carbonyl]thiophene- 2-carboxamide | A | 2VQM | 0.73 | |
BTH | 4-OXO-3-{6-[4-(QUINOXALIN-2-YLAMINO)- BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID | A | 1RWO | 0.7 | |
PL1 | COBALT (III)-DEGLYCOPEPLEOMYCIN | B | 1AO1 | 0.7 | |
G95 | N-[(1S)-2-amino-1-phenylethyl]- 5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene- 2-carboxamide | A,B | 3E87 | 0.72 | |
BMV | 3-BENZYL-1-(1H-IMIDAZOL-4-YLMETHYL)- 4-(THIEN-2-YLSULFONYL)-2,3,4,5- TETRAHYDRO-1H-1,4-BENZODIAZEPINE- 7-CARBONITRILE | B | 1SA5 | 0.73 | |
PMY | AGLYCON OF PEPLOMYCIN | A | 1AO4 | 0.71 | |
PMY | AGLYCON OF PEPLOMYCIN | A | 1AO2 | 0.71 | |
796 | N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]- 5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE- 2-CARBOXAMIDE | A | 2GU8 | 0.7 | |
C60 | [[[3-(2-METHYL-PROPANE-2-SULFONYL)- 1-BENZENYL]-2-PROPYL]-CARBONYL- HISTIDYL]-AMINO-[CYCLOHEXYLMETHYL]- [2-HYDROXY-4-ISOPROPYL]-PENTAN- 5-OIC ACID BUTYLAMIDE | A | 1RNE | 0.79 | |
IZ5 | N-{(1S)-2-{4-[(5S)-1,1-dioxido- 3-oxoisothiazolidin-5-yl]phenyl}- 1-[4-(3-phenylpropyl)-1H-imidazol- 2-yl]ethyl}-3-fluorobenzenesulfonamide | A | 2VEY | 0.72 | |
F32 | (5S)-5-{4-[(2S)-2-(1H-BENZIMIDAZOL- 2-YL)-2-(1,3-BENZOTHIAZOL-2-YLAMINO)ETHYL]PHENYL}ISOTHIAZOLIDIN- 3-ONE 1,1-DIOXIDE | A | 2CNF | 0.7 | |
HBN | N-(2-NAPHTHYL)HISTIDINAMIDE | B | 1VEA | 0.7 | |
GSI | 2-(5-chlorothiophen-2-yl)-N-[(3S)- 1-(4-{2-[(dimethylamino)methyl]- 1H-imidazol-1-yl}-2-fluorophenyl)- 2-oxopyrrolidin-3-yl]ethanesulfonamide | A | 2VH0 | 0.72 |